Abstract
Background: Nanoemulsions are promising drug delivery systems for topical application owing to the high transdermal penetration.
Objective: Due to the side effects of existing anti-inflammatory drugs, much attention has been paid to natural products such as flavonoids. The aim of this work was to formulate luteolin nanoemulsion (LNE) and to evaluate its anti-inflammatory effect.
Methods: LNE was prepared using the low-energy spontaneous emulsion method and characterized by transmission electron microscopy (TEM), Fourier transform infrared (FTIR) spectroscopy and dynamic light scattering (DLS). The anti-inflammatory effect of LNE was assessed in formalin and acetic acid-induced inflammation methods (Whittle test). Treatment with LNE (i.p, 4 consecutive days, 40 mg/kg) was compared with diclofenac 25 mg/kg and normal saline. In the formalin test, data were recorded at 1, 2 and 4 hours after formalin injection and in the Wittle test, the extent of Evans blue leakage in the peritoneal cavity was considered as vascular permeability.
Results: Formalin-induced edema decreased in the LNE group, but this reduction was not significant (p > 0.05), however, in Whittle test, both LNE and diclofenac significantly reduced Evans blue leakage compared with the group treated with acetic acid alone (p < 0.05).
Conclusion: Our results confirm the anti-inflammatory effect of LNE and give up a new platform for the design and development of bio-based carriers for more successful drug delivery.
Keywords: Luteolin, anti-inflammatory effect, nanoemulsion, formalin test, whilttle method, characterization.
[http://dx.doi.org/10.18632/oncotarget.23208] [PMID: 29467962]
[http://dx.doi.org/10.1093/bja/77.1.11] [PMID: 8703619]
[http://dx.doi.org/10.1146/annurev-immunol-032713-120145] [PMID: 24655300]
[http://dx.doi.org/10.1016/j.fct.2012.04.020] [PMID: 22542922]
[http://dx.doi.org/10.1016/j.foodchem.2008.06.064]
[http://dx.doi.org/10.1080/19390211.2017.1326431] [PMID: 28558255]
[http://dx.doi.org/10.7314/APJCP.2014.15.14.5501] [PMID: 25081655]
[http://dx.doi.org/10.1155/2013/485201] [PMID: 23840918]
[http://dx.doi.org/10.1016/j.jnutbio.2010.01.011] [PMID: 21036586]
[http://dx.doi.org/10.1016/j.lfs.2007.09.028] [PMID: 17977562]
[http://dx.doi.org/10.1023/B:MCBI.0000044364.73144.fe] [PMID: 15543940]
[http://dx.doi.org/10.3390/molecules18078083] [PMID: 23839113]
[http://dx.doi.org/10.1002/cpim.83] [PMID: 31483106]
[http://dx.doi.org/10.3390/pharmaceutics13081218] [PMID: 34452179]
[http://dx.doi.org/10.1021/acsomega.0c05142] [PMID: 33553902]
[http://dx.doi.org/10.1021/acsomega.1c05628] [PMID: 35036768]
[http://dx.doi.org/10.4103/0975-9476.140474] [PMID: 25336847]
[http://dx.doi.org/10.1055/s-0029-1185704] [PMID: 19452438]
[http://dx.doi.org/10.1080/03601234.2021.1879595] [PMID: 33560903]
[http://dx.doi.org/10.1016/j.jep.2018.05.019] [PMID: 29801717]
[http://dx.doi.org/10.1055/s-0028-1088314] [PMID: 18937165]
[http://dx.doi.org/10.1155/2015/967053] [PMID: 26236111]
[http://dx.doi.org/10.1016/j.cbi.2012.01.005] [PMID: 22342831]
[http://dx.doi.org/10.1016/j.bbamcr.2014.05.014] [PMID: 24892271]
[http://dx.doi.org/10.1111/1750-3841.13300] [PMID: 27095513]
[http://dx.doi.org/10.1155/2018/6123094] [PMID: 30112161]
![Wayfinder Image](/images/wayfinder.jpg)